Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study

Introduction: Reliable biomarkers of response to mTOR inhibition are yet to be identified. As mTOR is heavily implicated in cell-metabolism, we investigated the relation between BMI variation and outcomes in metastatic breast cancer (mBC) patients treated with everolimus. Results: we found a linear...

Descripción completa

Detalles Bibliográficos
Autores principales: Corona, Silvia P., Giudici, Fabiola, Jerusalem, Guy, Ciruelos, Eva, Strina, Carla, Sirico, Marianna, Bernocchi, Ottavia, Milani, Manuela, Dester, Martina, Ziglioli, Nicoletta, Barbieri, Giuseppina, Cervoni, Valeria, Montemurro, Filippo, Generali, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289535/
https://www.ncbi.nlm.nih.gov/pubmed/32577163
http://dx.doi.org/10.18632/oncotarget.27612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289535/
https://www.ncbi.nlm.nih.gov/pubmed/32577163
http://dx.doi.org/10.18632/oncotarget.27612

Ejemplares similares